Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice

Cancer Research

Volumn 65, Issue 23, 2005, Pages 10838-10846

  Chen, Yue ^a   Li, Ying Hua ^a   Chen, Xi Ping ^b   Gong, Li Min ^c   Zhang, Shu Ping ^a   Chang, Zhi Jie ^a   Zhang, Xiu Fang ^a   Fu, Xin Yuan ^a,d   Liu, Li ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ERYTHROPOIETIN RECEPTOR; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLALANINE; PROTEIN KINASE B; PROTEIN NOK; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL DEATH; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; MOUSE; NOK ONCOGENE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BINDING SITES; CASPASE 3; CASPASES; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; CONSERVED SEQUENCE; ENZYME ACTIVATION; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PHENYLALANINE; PHOSPHORYLATION; POINT MUTATION; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE ALIGNMENT; TRANSFECTION; TYROSINE;

EID: 28244476479     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1091     Document Type: Article

References (20)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355-65.
2. Hunter T. Signaling-2000 and beyond. Cell 2000;100: 113-27.
3. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1998;1378:F79-113.
4. Mohammadi M, Dikic I, Sorokin A, Burgess WH, Jaye M, Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol Cell Biol 1996;16:977-89.
5. Foehr ED, Raffioni S, Murray-Rust J, Bradshaw RA. The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain. J Biol Chem 2001;276:37529-36.
6. Fambrough D, McClure K, Kazlauskas A, Lander ES. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 1999;97:727-41.
7. Mohammadi M, Dionne CA, Li W, et al. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 1992;358:681-4.
8. Mohammadi M, Honegger AM, Rotin D, et al. A tyrosine-phosphorylated carboxy-termjnal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-γ 1. Mol Cell Biol 1991;11:5068-78.
9. Tyson DR, Larkin S, Hamai Y, Bradshaw RA. PC12 cell activation by epidermal growth factor receptor: role of autophosphorylation sites. Int J Dev Neurosci 2003;21:63-74.
10. Hart KC, Robertson SC, Donoghue DJ. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell 2001;12:931-42.
11. Liu L, Yu XZ, Li TS, et al. A novel protein tyrosine kinase NOK that shares homology with platelet-derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice. Cancer Res 2004;64:3491-9.
12. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915-25.
13. Mohammadi M, Schlessinger J, Hubbard SR. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 1996;86:577-87.
14. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91.
15. Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005;5:355-66.
16. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
17. Valius M, Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993;73:321-34.
18. Tulasne D, Paumelle R, Weidner KM, Vandenbunder B, Fafeur V. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol Biol Cell 1999;10:551-65.
19. Jones N, Master Z, Jones J, et al. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 1999;274:30896-905.
20. Madhani HD. Accounting for specificity in receptor tyrosine kinase signaling. Cell 2001;106:9-11.